| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.42B | 9.43B | 9.04B | 9.66B | 9.52B | 8.10B |
| Gross Profit | 5.04B | 4.98B | 4.94B | 5.12B | 4.89B | 4.14B |
| EBITDA | 2.46B | 2.41B | 2.49B | 2.78B | 2.80B | 2.22B |
| Net Income | 1.31B | 1.26B | 1.32B | 1.48B | 1.52B | 1.21B |
Balance Sheet | ||||||
| Total Assets | 19.55B | 19.95B | 19.25B | 18.86B | 17.88B | 16.94B |
| Cash, Cash Equivalents and Short-Term Investments | 9.45B | 9.87B | 8.89B | 8.50B | 8.54B | 7.67B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 1.27B | 1.53B | 1.52B | 1.66B | 1.71B | 1.62B |
| Stockholders Equity | 18.28B | 18.42B | 17.73B | 17.20B | 16.17B | 15.33B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.90B | 1.28B | 930.29M | 1.61B | 2.07B |
| Operating Cash Flow | 0.00 | 2.01B | 1.83B | 1.61B | 2.26B | 2.53B |
| Investing Cash Flow | 0.00 | -392.61M | -575.25M | -1.14B | -348.86M | -187.25M |
| Financing Cash Flow | 0.00 | -684.30M | -883.88M | -560.86M | -763.17M | -438.38M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
85 Outperform | ¥223.93B | 7.03 | ― | 2.33% | 31.97% | 60.30% | |
78 Outperform | ¥271.75B | 24.11 | ― | 1.17% | 23.18% | 15.70% | |
77 Outperform | ¥21.81B | 14.20 | ― | 3.31% | 0.11% | -3.03% | |
74 Outperform | ¥301.50B | 11.92 | 7.86% | 2.55% | 5.68% | 41.20% | |
74 Outperform | ¥88.92B | 7.58 | ― | 3.85% | 16.93% | 14.13% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥120.11B | 26.06 | 2.64% | 2.30% | 0.90% | 15.74% |